Daunorubicin
داونوروبیسین
🎗️ Antineoplastic And Immunomodulating AgentsAnthracycline
Market / country: 🇺🇸 USA
Cerubidine (US)
🧮 Dose calculator
Acute myeloid leukaemia (AML) · Regimen source: FDA Daunorubicin · Dosage and Administration
- • Only under an oncologist in an equipped centre. Calculator = label mg/m² × BSA (Mosteller); protocol, cycle interval and adjustment for CBC and renal/hepatic function rest with the oncology team. FDA Daunorubicin · Dosage and Administration
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to daunorubicin. FDA Daunorubicin · Contraindications
Warnings
- • Cardiotoxicity above cumulative 400–550 mg/m² in adults (300 mg/m² in children over 2, 10 mg/kg under 2); severe myelosuppression; only by physicians experienced in leukaemia therapy. FDA Daunorubicin · Warnings
Formulations
- 5 mg/mL (20 mg/4 mL, 50 mg/10 mL) — injection 🇺🇸 USA FDA Daunorubicin · How Supplied
👥 Special populations
- 🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Daunorubicin · Pregnancy
“Daunorubicin hydrochloride may cause fetal harm when administered to a pregnant woman.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Daunorubicin · Nursing Mothers
“Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from daunorubicin, mothers should be advised to discontinue nursing during daunorubicin therapy.”
- 👶 ChildrenUse with caution
Label: children have lower cumulative limits (300 mg/m² over 2 years, 10 mg/kg under 2) — cardiotoxicity. FDA Daunorubicin · Warnings
“The incidence of myocardial toxicity increases after a total cumulative dose exceeding 400 to 550 mg/m 2 in adults, 300 mg/m 2 in children more than 2 years of age, or 10 mg/kg in children less than 2 years of age.”
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA208759
- DailyMed (FDA label)FDA Daunorubicin
- MedlinePlus (NIH)Daunorubicin
- WHO ATC/DDDL01DB02
- Darooyab (Iran)Daunorubicin
🇮🇷 Registered in Iran Darooyab · G-979/Daunorubicin
Dosage forms with Iranian generic codes, per Darooyab.
- 00384 · DAUNORUBICIN HCL 20MG VIAL · ویال داونوروبیسین هیدروکلراید ۲۰ میلیگرم
- 52506 · DAUNORUBICIN (AS HYDROCHLORIDE) INJECTION, SOLUTION PARENTERAL 2 mg/1mL 10 mL · محلول تزریقی داونوروبیسین (معادل هیدروکلراید) ۲ میلیگرم / ۱ میلیلیتر ۱۰ میلیلیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Daunorubicin · How SuppliedFDA Daunorubicin · Dosage and AdministrationFDA Daunorubicin · ContraindicationsFDA Daunorubicin · WarningsFDA Daunorubicin · PregnancyFDA Daunorubicin · Nursing MothersFDA Daunorubicin · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-979/Daunorubicin
- Clinical review⚠ Unverified